Unilever announced that it has acquired a minority stake in Gallinée.
Gallinée, founded by French pharmacist Marie Drago in 2016, utilizes a patented combination of pre-, pro- and post-biotics to create personal care items targeting issues such as acne and eczema for sensitive skin. It is carried at department stores and pharmacies in the United Kingdom and France, such as Harvey Nichols.
Read more: Bacteria-rich Beauty
The investment wraps up Gallinée’s series A financing; Unilever is the leading investor.
The financing will go toward extending the range, research and development and talent at the brand. This includes expanding the company’s global retail operation and its e-commerce presence, as well as hiring an experienced head of e-commerce.
Said Anna Ohlsson-Baskervill, a director with Unilever Ventures: “We have been impressed by Gallinée’s level of innovation and consistency. It is rare to find such young brands with the right mix of science and consumer focus. I look forward to working with Marie and her team to build upon the company’s momentum and many growth opportunities”